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Abstract The digoxigenin derivative N-hydroxysuccinimidyl di- 
goxigenin-3-O-methylcarbonyl-c-aminocaproate (HDMA) has 
been shown to covalently label the ouabain binding site of the 
Na,K-ATPase e subunit [Antolovic et al. (1995) Eur. J. Biochem. 
227, 61-67]. In the present study we observed both, labeling and 
inactivation of the activity, of wild type Na,K-ATPase overex- 
pressed in Xenopus oocyte. In contrast, no significant inhibition 
and no labeling could be detected when a Cys- l l3 of the first 
transmembrane segment was mutated to serine, although the af- 
finity of this mutant for digoxigenin or HDMA measured in acute 
inhibition experiments was similar to the wild type. This indicates 
that after docking of its genin moiety, HDMA can form a thio- 
ester bond with Cys-l l3. 
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1. Introduction 
The Na,K-ATPase is an integral membrane protein responsi- 
ble for the transport of Na ÷ and K ÷ across the cell membrane 
against heir electrochemical gradient. It is also the specific 
target of widely used drugs, the cardiac steroids. A natural 
endogenous cardiac steroid may also be involved in the physi- 
ological control of the Na,K-ATPase activity [1]. 
The structure of the binding site of cardiotonic steroid on the 
~z subunit has been extensively studied [2,3] and it is now clear 
that several of the short extracellular loops connecting the 
transmembrane segments of the cz subunit are involved. Muta- 
tions affecting several amino acids of the H1-H2 loop [3], a 
tyrosine in the H3-H4 loop [4], a threonine in the H5-H6 [5,6] 
and an arginine of the H7-H8 loop [7] significantly modify the 
cardiotonic steroid affinity. 
At least wo amino acids of the outer third of the first trans- 
membrane segment (H 1) appear to be important determinants 
of ouabain binding. Canessa et al. [8] have identified a cysteine 
which was mutated into a phenylalanine or a tyrosine in an 
ouabain-resistant MDCK cell line. Similarly Askew and Lin- 
grel [9] observed the Cys to Tyr mutation at the same position 
in an ouabain-resistant HeLa cell line. Site directed mutations 
at the corresponding sites in Xenopus [8] or sheep [10] czl sub- 
units yielded an ouabain-resistant phenotype. Similarly, the 
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Abbreviations." HDMA, N-hydroxysuccinimidyl digoxigenin-3-O-meth- 
ylcarbonyl-e-aminocaproate. Enzyme: Na÷/K+-ATPase, Na+/K+-trans- 
porting ATPase (EC 3.6.1.37). 
tyrosine at position 108 in the sheep :zl subunit was also shown 
to be a determinant of ouabain binding [10]. 
Naturally occurring cardiotonic steroids are glycosylated 
with 1-3 sugar esidues in position 3 of the steroid nucleus and 
the presence of these sugar groups results in a roughly 20-50- 
fold increase in affinity compared to that of the corresponding 
aglycone [11]. Modification of the protein domain that binds 
the sugar moiety of glycoside compounds would be expected 
to alter the affinity of glycosides without changing the affinity 
for the corresponding a lycone. Up to now investigators have 
failed to identify mutants or isoforms with a significantly al- 
tered glycoside/aglycone affinity ratio [6,8,10] although there 
was a very large range of affinity for ouabain in the studied 
mutants. Therefore the nature of the sugar binding site remains 
to be determined. 
Antolovic et al. [12] have recently shown that it is possible 
to label the 0¢ subunit of purified pig kidney Na,K-ATPase 
by exposure to the cardiac steroid derivative N-hydroxysuc- 
cinimidyl digoxigenin-3- O methylcarbonyl-e-aminocaproate 
(HDMA), a compound in which a reactive hydroxysuccin- 
imidyl group is located at the end of a 6-carbon chain which 
is attached to position 3 of the steroid ring of digoxigenin. They 
proposed that HDMA could form a thioester with a sulfhydryl 
group located in one of the first two transmembrane domains 
of the ~ subunit, e.g. with Cys-104 in H1 or Cys-138 in H2. 
Since it was not possible to determine which one of the two 
cysteines was modified by sequence analysis of HDMA-labeled 
peptides, we investigate in this study the binding of HDMA to 
wild type Xenopus czl subunit and mutants in which Cys-113 
was replaced by either a serine or a tyrosine residue (C113S, 
C113Y). The Xenopus oocyte expression system allowed us to 
study both the labeling of the :z subunit protein and the func- 
tional effects of HDMA binding, and to demonstrate hat 
HDMA does indeed form a bond with Cys-ll3 in H1 but not 
with Cys-147 in H2 and thereby inhibits the Na,K-pump func- 
tion. 
2. Material and methods 
2.1. Expression of wild-type and mutant Na+/IC-ATPase 
Stage V-VI Xenopus oocytes were obtained, prepared and main- 
tained as described earlier [13], and injected with 7 ng of cRNA of the 
subunit (wild-type or mutant) and 1 ng of cRNA of the fll subunit 
(wild-type) of the Xenopus laevis Na+/K+-ATPase [14]. The oocytes 
were kept in amphibian Ringer solution for 3 days to allow the expres- 
sion of the exogenous Na÷/K+-ATPase and then loaded with sodium 
by exposure to a K-free solution (in mM: Na-gluconate 80, NaHCO3 
9.6, MgCI2 8.2, Na-MOPS 20, pH 7.0). Na+oloaded oocytes were ex- 
posed to 100 nM HDMA in the same solution for 12 h at 19°C and used 
either for electrophysiological measurements or for measurement of 
labeling. 
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2.2. Electrophysiological measurements 
The Na+/K÷-pump current was measured as described earlier [13] 
using the 2-electrode voltage clamp technique as the outward current 
induced by addition of 10 mM K ÷ to K*-free solution (in mM): Na ÷ 
80, Ba 2+ 5, Mg 2÷ 0.82, tetraethylammonium (TEA) 10, Ca 2+ 0.41, [N- 
morpholino]propanesulfonic acid(MOPS) 5, C1 22, gluconate 80, pH 
7.0. Potassium was added as K-gluconate. We have shown earlier that 
the Na,K-pump current measured in these conditions at a membrane 
potential of -50 mV is a reliable measure of the Na,K-pump activity 
present in the oocyte membrane [13,15]. 
2.3. Analysis of membrane labeling 
Forty to 50 oocytes of each experimental group were homogenized 
at 4°C with a Pasteur pipette in 25/ll/oocyte of HEPES buffer, pH 7.0, 
containing (in mM): NaC150, MgC12 10, PMSF 0.5 and 5/lg/ml of each 
leupeptin, antipain and pepstatin. The homogenate was centrifuged 
twice at 1000 x g for 10 min and the supernatant a 10,000 × g for 20 
min at 4°C as described [16]. For SDS-PAGE the pellet was dissolved 
in 0.5/.d/oocyte of 3.7% SDS. Electrophoresis was done according to 
the procedure of Laemmli [17] in 8 13% and 10% SDS-polyacrylamide 
gels. Western blotting was carried out according to the prescription of 
Boehringer Mannheim using the Dig-detection kit for chemilumines- 
cence. Briefly after, the SDS-PAGE protein was transferred on the 
nitrocellulose membrane. The membrane was blocked with the 
Boehringer blocking solution and additionaly incubated with specific 
polyclonal anti-digoxigenin-POD antibodies [12]. The HDMA labeled 
c~ subunit was detected with polyclonal antibodies against he ~ subunit 
of Na+/K+-ATPase from Bufo marinus [18] with the chemiluminescence 
method escribed above. 
Results are given as mean + S.E.M. Statistical calculation for signif- 
icant differences between group means were made using the Student's 
t-test using the InStat version 2 of GraphPad Software. 
3. Results 
3.1. Affinity labeling of wild-type and mutant Xenopus ctl 
subunits 
When oocytes were treated with 0.1 /.tM HDMA covalent 
labeling could only be detected in oocytes overexpressing the 
Na,K-pump after wild-type ct subunit cRNA injection (Fig. 
1B). No HDMA labeling could be detected in oocytes express- 
ing the Cl13S mutant. HDMA labeling was also absent in 
non-injected control oocytes probably because of the relatively 
low level of expression of the endogenous Na,K-pump. An 
excess of ouabain present during HDMA labeling protected 
against he incorporation of the digoxigenin derivative. There- 
fore, it was possible to detect HDMA affinity labeling of the 
cardiac steroid binding site of the Xenopus ~1 subunit expressed 
at a high level in oocyte as well as in isolated pig kidney Na+/ 
K+-ATPase [12] and in embryonic hick heart cells [19]. Differ- 
ences in the labeling of ~t subunits in oocytes expressing the 
wild-type and the Cl13S mutant c~ subunit are not due to 
variations in protein expression as shown by immunoblotting 
with anti-c~ antibodies (Fig. 1A) nor to failure of expression of 
active Na,K-pump mutants at the oocyte surface (see legend of 
Fig. 1). 
3.2. Functional measurements 
Electrophyiological measurements of the K+-stimulated out- 
ward current showed first that wild-type and mutant Na,K- 
ATPases were expressed at a high level, clearly larger than the 
level of the endogenous Na,K-pump (Fig. 2). Overnight expo- 
sure to 100 nM HDMA treatment induced partial inactivation 
of the Na,K-pump activity both in the non-injected oocyte 
(inactivation of the endogenous Na,K-ATPase) and in oocytes 
expressing the wild-type ~1 Xenopus. A much smaller inhibition 
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Fig. 1. Western blots of HDMA-labeled wild-type and mutant Xenopus 
laevis ct subunits. Xenopus oocytes were injected with Xenopus wild-type 
(WT) or mutant (C113S) ~ subunit, and wild-type fl subunit cRNA as 
described in Material and Methods. After 12 h incubation in 100 nM 
HDMA, microsomes were prepared, subjected to SDS-PAGE and 
transferred to nitrocellulose. (A) Immunodetection f the c~ subunit 
with specific anti-~ antibodies after stripping of the membrane shown 
in B. (B) Labeling of the ~ subunit with HDMA. Labeling was revealed 
with anti-digoxigenin antibodies. Measurements of the Na,K-pump 
currents in oocytes from the same batch and treated in the same manner 
yielded the following values: 85 + 12 nA in non injected oocytes, 
423 + 50 nA in oocytes injected with wild-type ~1 cRNA and 303 + 61 
nA in oocytes injected with the C113S mutant c~l cRNA. The presence 
of I mM ouabain in the solution containing HDMA is indicated in the 
bottom line. This is the result of 1 out of 4 similar experiments. 
of the Na,K-pump function was observed in oocytes expressing 
the C113S or C113Y mutants (Fig. 2). The small decrease of 
the Na,K-pump current observed in these groups can entirely 
be attributed to inactivation of the endogenous (wild-type) 
Na,K-ATPase of the oocyte. 
HDMA affinity labeling of the Na,K-ATPase can be pre- 
vented by ouabain and it is therefore probable that the genin 
moiety of HDMA must first dock into the cardiac steroid 
binding site before the thioester bond can form between the 
hydroxysuccinimidyl reactive group and a nearby -SH group 
[12]. Failure of HDMA labeling in the mutants might then be 
explained either by low affinity of the steroid for the mutant 
or by the absence or inaccessibility of the -SH group. The 
former possibility is, however, unlikely for the C113S mutant 
since we had shown earlier that the affinity of the C113S for 
ouabain or strophanthidin was very close to that of the wild- 
type [8]. To confirm that this applied also to the genin of 
HDMA we determined the inhibition kinetics of wild-type and 
mutants ~ subunit for digoxigenin. The Na,K-pump current 
was measured in the absence and presence of 0.1, 1.0 and 10 
/IM of digoxigenin. These experiments showed no difference in 
the half maximal inhibition of the wild-type (1.16 + 0.61/IM, 
n -- 7) and the C113S mutant (0.97 + 0.24 /IM, n = 7). The 
C113Y mutant was, however, more resistant to the digoxigenin 
(21.7 + 10.4/~M, n = 3). Finally we measured the apparent af- 
finity of HDMA for the wild-type and C113S mutant in acute 
inhibition experiments. Oocytes expressing high level of artifi- 
cially expressed Na,K-pump (i.e., with an Na,K-pump current 
more than twice larger than the current in oocyte injected with 
the fl subunit alone) were exposed to concentrations of 0.1, 1.0 
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Fig. 2. Inactivation of the Na,K-pump current by HDMA in Xenopus 
laevis oocytes expressing endogenous, exogenous wild-type and C 113S 
and C113Y mutant cz subunits of Xenopus laevis. The Na,K-ATPase 
activity was measured as the Na,K-pump current (nA) after overnight 
exposure to 100 nM HDMA (dark columns) or in non-exposed control 
oocytes (light columns). The effect of HDMA is shown in non-injected 
oocytes (n.i., control n = 15, HDMA n = 15), in oocytes injected with 
wild-type c~ and fl cRNA (WT, control n = 13, HDMA n = 15), or in 
oocytes injected with mutant ~ cRNA and wild-type fl cRNA (C113S: 
control n = 14, HDMA n = 13; C 113Y: control n = 13, HDMA n = 10). 
The percentage ofinhibition induced by HDMA is indicated below the 
columns. 
and 10/IM HDMA for 3-5 min at each concentration. The half 
inhibition constant of HDMA was 3.9 + 0.6 (n -- 7) in wild-type 
and 2.5 + 0.25 in the Cl13S mutant (P = 0.035), indicating a
slightly higher affinity for the C113S mutant. Both these values 
were slightly higher than those obtained for digoxigenin which 
may be explained by a slower rate constant due to the steric 
hindrance caused by the additional side chain in HDMA. 
We also attempted to label the czl subunit of Bufo marinus, 
an isoform which is moderately ouabain-resistant (Ki around 
50/IM) [20]. The conserved cysteine of i l l  is present in the Bufo 
c~l subunit sequence (Cys-l l l ) .  No specific labeling could be 
detected after overnight exposure to 100 nM HDMA (data not 
shown) and functional measurements could not detect any inhi- 
bition of the Bufo Na,K-ATPase expressed in oocytes (Na,K- 
pump current 263 + 22 nA (n = 27) after HDMA vs. 244 + 25 
nA (n = 25) control, P > 0.1). 
4. Discussion 
The present study shows first that it is possible to use the 
protein reactive HDMA to specifically label the cardiac steroid 
binding site of an Na,K-ATPase artificially expressed in Xen- 
opus laevis oocytes. Affinity labeling was detectable only in a 
ouabain-sensitive (Xenopus ~1) but not in an ouabain-resistant 
(Bufo marinus c~l) isoform, indicating that sufficient binding of 
the cardiac steroid is necessary before the covalent labeling can 
occur. This also suggests that Cys-l l3 is not easily accessible 
as predicted by its location inside the membrane in the presently 
best accepted topology models. In fact, other -SH reagents, 
such as the fluorescent coumarinyl maleimido derivative do not 
label this cysteine [21]. It is also possible that formation of the 
thioester can occur only after a cardiotonic steroid-induced 
conformational change. HDMA not only labeled the wild-type 
c~ subunit of Xenopus Na,K-ATPase but also partially inhibited 
the transport function of this enzyme. 
Both results of affinity labeling and of functional studies 
confirm the hypothesis put forward by Antolovic et al. [12] that 
HDMA forms a thioester bond with the cysteine located in the 
outer half of first transmembrane segment, Cys- 113 in the Xen- 
opus czl sequence. Mutation of Cys-113 to serine prevents la- 
beling. However, it does not affect the acute inhibition of di- 
goxigenin or of HDMA (as shown above) by non-covalent 
binding either to ouabain or to strophanthidin [8]. Together 
with the biochemical data of Antolovic et al. [12], this result 
indicates that the hydroxysuccinimidyl group of HDMA can 
form a thioester bond with Cys-113 in the first transmembrane 
segment after the genin moiety of HDMA has been bound to 
the cardiac steroid site on the cz subunit. Another explanation 
for the present observation could be that the C113S mutant 
exists in an altered conformation i  which the labeling site is 
not exposed to the reactive group of HDMA. This seems highly 
unlikely considering that the Na,K-pump function of this mu- 
tant is very similar to the wild-type [4], the binding of aglycone 
is not modified [4] and the labeled cysteine is located in the first 
pair of the transmembrane s gment [12]. 
Studies by Canessa et al. [8] and O'Brien et al. [22] on the 
effects of mutations of the cysteine in H1 of Xenopus or sheep 
czl subunit and the amino acids in the extracellular H1-H2 loop 
show that the affinity of an aglycone (strophanthidin or 
ouabagenin) is lowered to the same extent as that of a glycoside 
(ouabain). If any of these amino acids were directly involved 
in the recognition of the sugar moiety of the glycoside, a 
stronger effect on the glycoside would be expected. The authors 
therefore conclude that the sugar moiety does not bind to these 
residues. Moreover, in a recent report on the effect of the 
mutation of Cys-104 of the human czl subunit in H1C1 cells on 
the discriminatory power between digoxin and digitoxin, 
Askew and Lingrel [9] proposed that Cys-104 may interact with 
the C-14-OH group between the C and the D rings. These 
conclusions are somewhat in conflict with the affinity labeling 
data of McParland et al. [23] which showed that the protein- 
reactive 24-azido 3fl-digitoxoside labeled the sequence 
W310LEA313 in the extracellular H3-H4 loop. The latter se- 
quence is adjacent o the sequence Y308TW310 which has a 
sequence similarity with the steroid dehydrogenase, the h-pro- 
gesterone and the h-glucocorticoid receptor and has been pro- 
posed to interact with the unsaturated lactone ring of cardiac 
steroids through a triple hydrogen bond [24]. 
Arystarkhova et al. [25] conclude from their studies with the 
VG4 antibody directed towards the extracellular H1-H2 loop 
and enhancing cardiac glycoside binding that this loop may 
play a modulary role rather than directly participating in the 
binding site structure for cardiac glycosides. Such data point 
to the possibility that changes in the free energy of interaction 
with the cardiac steroids digoxin and digitoxin observed after 
single site mutation may reflect he sum of dipole interactions 
and Van der Waals forces rather than hydrogen bonds. 
We could previously show by molecular modeling that the 
length and the proper spacial orientation of the sulfhydryl- 
reactive substituents at the C-3-OH group of the A ring of 
digoxigenin is of prime importance for affinity labeling [12]. 
Comparison of the 3-dimensional models of the various pro- 
tein-reactive digoxigenin derivatives with digoxigenin-3-O-di- 
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gitoxoside led to the suggestion that the reactive SH group was 
also involved in the recognition of the sugar moiety of the 
cardiac glycoside [12]. Although the results of the present study 
cannot resolve the question of the binding site for the sugar part 
of the cardiac glycoside, the data in this study and in the 
preceding paper [12] show that the genin moiety is bound to the 
subunit in such a position, that the Cys-113 of H1 is located 
within reach of a 4- to 7-carbon chain from the C3 position of 
the steroid ring. 
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